Anhui Heryi Pharmaceutical Co. Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | The main business of Anhui Yiyi Pharmaceutical Co., Ltd. is the research and development, production, and sales of advanced pharmaceutical intermediates, raw materials, and related products. The main product categories include anti allergic, anti thrombotic, antioxidant, gastric ulcer, antiviral, antipyretic and analgesic, and ultraviolet absorbents. The main products of the company are advanced pharmaceutical intermediates and related products of characteristic raw materials such as propranolol, salgrel hydrochloride, 4-hydroxycoumarin, resveratrol, mosapride, celecoxib, biphenyl diester, dibenzoyl resorcinol, etc. They have relatively complex structures, high research and development difficulties, high technical barriers, unique production processes, and high added value. The core management team of the company has over 20 years of industry experience, accumulating rich research and development technology and industry chain resources. The company has established long-term and stable cooperative relationships with downstream customers, mainly targeting overseas markets such as South Korea and Japan. The end customers include well-known pharmaceutical companies such as Korean Big Bear Pharmaceuticals, Korean CKD, Korean Nippon Pharmaceuticals, Sumitomo Pharmaceuticals, Sanyo Chemicals, and Japanese Medical Industry. |
| Headquarter | Chuzhou City |
| Establish Date | 10/25/2007 |
| Listed Code | 430478.BJ |
| Listed Date | 2/23/2023 |
| Chairman | Dong Laishan. |
| CEO | Dong Laishan. |
| Website | www.heryipharma.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
